HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
Retrovirology. 2012;9(Suppl 2):P131 DOI 10.1186/1742-4690-9-S2-P131
LCC Subject Category: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Country of publisher: United Kingdom
Language of fulltext: English
Full-text formats available: PDF, HTML
AUTHORS
Volk JE
Hessol NA
Gray GE
Kublin JG
Churchyard G
Mlisana K
Nchabeleng M
Buchbinder SP
Bekker L
EDITORIAL INFORMATION
Time From Submission to Publication: 11 weeks
Abstract Full Text
None